This antibody was purified from hybridoma (clone 8D2) supernatant using protein G agarose. This hybridoma was established by fusion of mouse myeloma cell P3U1 with Wister rat lymph node immunized with mouse SiglecE transfected L cell.
Target:
Siglec-E/CD170
Application Dilute:
IP: 2 µg/300 µL of cell extract from 5x106 cells. FCM: 25 µg/mL (final concentration)
* VAT and and shipping costs not included. Errors and price changes excepted